pharmaphorum

JULY 8, 2022

The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the clinical trial space. Hybrid or decentralised clinical trials (DCTs) have gained traction as technology, infrastructure and knowledge have evolved to support their use. Source: Izmailova et al, 2017.

Clinical Trials 100

Clinical Trials Clinical Trials Trials Regulation 100

AuroBlog - Aurous Healthcare Clinical Trials blog

MARCH 17, 2024

The Department of Pharmaceuticals (DoP) has issued a new Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, permitting pharma companies to provide brand reminders such as informational and education items and free samples to medical professionals with restrictions on sample packs and total value.

Pharma Companies 189

Pharma Companies Branding Marketing Clinical Trials 189

pharmaphorum

JUNE 14, 2022

Despite more treatment options being a positive, Ben Hargreaves finds that this has raised issues over single-region clinical trials, leading to the FDA rejecting certain treatments and clarifying what is required for approval. Only last month , the US company Merck agreed to pay a potential $1.4 Single-region concerns.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Development 98

pharmaphorum

FEBRUARY 1, 2022

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. The post Synthetic control arms in clinical trials: Making it happen appeared first on. But what does it take to implement these innovations?

Clinical Trials 104

Clinical Trials Clinical Trials Trials Engineer 104

pharmaphorum

MAY 30, 2022

Josh Sackman, president and co-founder of AppliedVR, and Web Sun, president and co-founder of Komodo Health, relay how their newly formed collaboration reshapes the clinical trial process by using data, helping to cut costs and allowing for evaluation of broader patient populations. .

Clinical Trials 97

Clinical Trials Clinical Trials Trials Big Data 97

pharmaphorum

FEBRUARY 11, 2021

Pharma companies face many challenges when involving patients in the design of clinical trials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. Involving patients in discussions.

Clinical Trials 101

Clinical Trials Clinical Trials Trials Clinical Research 101

pharmaphorum

MAY 27, 2022

This is the second in a two-part series examining how pharma can embrace the DEI agenda to create more effective medicines through more representative clinical trials. The same principles are increasingly being applied to clinical trials to improve diversity, mitigate bias, and reinforce inclusion in clinical trials.

Clinical Trials 80

Clinical Trials Clinical Trials Trials Packaging 80

pharmaphorum

SEPTEMBER 7, 2022

Pharma has a great opportunity ahead of it when it comes to conducting representative clinical trials. The processes used are now seeing huge infrastructure commitments, in order to cement their place in the development of future products and trials. Whilst this is an early area of research, pharma can turn the dial now.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Genetics 98

World of DTC Marketing

JUNE 2, 2021

SUMMARY: Doctors said they were dissatisfied were marketing emails (46%), telephone sales calls with sales reps (42%), and both webinars and websites (each at 39%) from pharma companies, according to Indegene. 8ight: One of the best successes we had in email marketing was a copy that could be easily be sent to diabetes patients.

Doctor 180

Doctor Doctors Sales Marketing 180

XTalks

MAY 6, 2022

In this interview, Xtalks spoke with experts from eClinical Solutions , Katrina Rice, Chief Delivery Officer, Data Services; and Diane Lacroix, Vice President, Clinical Data Management, about clinical data management for modern day digital clinical trials. Data security: The clinical trial data is backed-up and secure.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Life Science 98

Pharmaceutical Technology

FEBRUARY 24, 2023

The EU is planning a sweeping revision of its pharma legislation in March, the largest change in 20 years. The overhaul will address drug marketing exclusivity length, pricing, patient access, innovation incentives, antimicrobial resistance, clinical trials, supply chain security and shortages, and environmental impact.

Regulation 162

Regulation Clinical Trials Clinical Trials Medicine 162

World of DTC Marketing

DECEMBER 1, 2020

Just look at any pharma product website that is nothing but a sales brochure in a majority of cases. ROI drives pharma companies. In the past, pharma product websites had a huge effect on whether a patient asks for an Rx. 5ive: It’s time to update clinical trial information. 3d render ).

Pharma Production 186

Pharma Production Pharma Companies Sales Production 186

pharmaphorum

MAY 24, 2022

It powers drug discovery, clinical trials, and operational performance. Organisations are missing out on the ability to harness their data to energise precision marketing and transform commercial performance. Securing advantages and market share is growing tougher. Data is the powerhouse of the pharmaceutical sector.

Marketing 111

Marketing Sales Life Science Pharma Companies 111

World of DTC Marketing

JANUARY 10, 2022

Pharma companies are flush with cash and looking to make deals, but there are still a lot of small biotech companies that don’t have enough money to launch their products entirely. A study in 2020 estimated that the median cost of getting a new drug into the market was $985 million, and the average price was $1.3

Production 213

Production Drugs Development Marketing 213

pharmaphorum

MAY 20, 2022

Last year, the company added clinical trials to the list with the launch of CVS Health Clinical Trial Services , an initiative that works with pharma companies on clinical trial recruitment and even hosts trial sites at certain retail locations. Take us back to May 2020.

Clinical Trials 90

Clinical Trials Clinical Trials Trials Clinical Research 90

Intouch Solutions

OCTOBER 13, 2023

Pharmaceutical companies can sponsor as well as provide these leaders. Pharmaceutical companies can increase diversity in their clinical trials. Companies can also support pre-existing SDOH research initiatives. Studies should include as detailed SDOH data as possible.

Pharma Companies 105

Pharma Companies Clinical Trials Clinical Trials Development 105

XTalks

JANUARY 20, 2025

Among these, mergers and acquisitions (M&As) have played a pivotal role in reshaping the industry landscape, enabling companies to bolster their portfolios, enhance R&D capabilities and expand their global market reach. Actavis Acquisition of Allergan Deal value : $70.5

Marketing 104

Marketing Botox Life Science Pharma Companies 104

World of DTC Marketing

MARCH 11, 2022

consumers’ trust in pharma is low, despite the industry’s contributions to ending the pandemic: Only 15% of U.S. consumers say they trust pharma companies more than they did before the COVID-19 pandemic, according to Accenture’s 2021 survey. What does this mean for DTC and HCP marketing?

Pharma Companies 212

Pharma Companies Vaccination Vaccine Drugs 212

XTalks

MAY 11, 2023

Clinical trials are essential for the development of new treatments for rare diseases, but they can be complex and challenging to execute. Patient input is a crucial component of rare disease clinical trials, as it can provide valuable insights into the patient experience and inform decisions about study design and implementation.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Development 97

pharmaphorum

DECEMBER 7, 2020

Bureaucracy, political upheaval, and lack of regulations continue to make Latin America a difficult market for European and North American pharma to enter – and COVID-19 has only worsened these issues. Developing market specialist Dr Zulf Masters OBE takes us through the nuances of being successful in this region.

Marketing 109

Marketing Regulation Production Medicine 109

Pharmaceutical Technology

SEPTEMBER 8, 2022

Find the leading API biologics companies in contract marketing. Pharmaceutical Technology has listed some of the top API biologics companies in contract marketing based on our intel, insights and decades-long experience in the sector.

Gene 100

Gene Marketing Vaccination Vaccine 100

Outsourcing Pharma

SEPTEMBER 26, 2024

The US big pharma company Pfizer has voluntarily withdrawn the oral sickle cell disease treatment Oxbryta from the market and halted clinical trials of the drug as data indicate a high risk of severe adverse events.

Pharma Companies 76

Pharma Companies Drugs Clinical Trials Clinical Trials 76

World of DTC Marketing

NOVEMBER 27, 2020

Moderna’s top management has, collectively, sold more than $350 million in stock or investments in the company over the course of this year. Pharma companies have also been capitalizing on the pandemic and positive press releases more broadly.

Vaccine 208

Vaccine Vaccination Pharma Companies Trials 208

World of DTC Marketing

MAY 16, 2022

The drug led to impressive blood sugar and body weight drops in clinical trials. The approval for tirzepatide—which Lilly will market under the brand name Mounjaro—isn’t for weight loss but Type 2 diabetes. Food and Drug Administration approved Eli Lilly’s novel treatment for diabetes. A matter of trust?

Drugs 218

Drugs Pharma Companies Clinical Trials Clinical Trials 218

XTalks

JANUARY 22, 2025

The heart and vascular medication market continues to be a critical focus area for pharma companies, with billions of dollars in sales generated annually. However, challenges such as patent expirations, generic competition and pricing pressures continue to shape the market landscape. In 2023, Pfizer generated $6.75

Sales 104

Sales FDA Approval Drugs Marketing 104

Pharmaceutical Technology

MARCH 17, 2023

As the field of digital therapeutics continues to broaden, specific uses in mental health and neurology are increasingly making headway for patients and on the market. At the same time, experts are saying developers in the field need to double down on securing clinical data to allow for its continued maturation.

Production 278

Production Development Pharma Companies Marketing 278

Delveinsight

AUGUST 23, 2021

The present treatment approach in the Von Hippel-Lindau therapy market revolves around controlling and preservation of functional parenchyma to avoid the morbidity associated with renal or adrenal loss. The drug is in one Phase I and two Phase II clinical trials to treat VHL-associated Renal Cell Carcinoma and Pheochromocytoma/ Paraganglioma.

Marketing 98

Marketing Clinical Trials Clinical Trials Trials 98

pharmaphorum

AUGUST 2, 2022

The potential for ADCs to combine the best of both mAbs and small molecule drugs means that there has been high interest in developing a successful compound since the first successful clinical trial in 1983. The post Oncology market dominance: As easy as ADC? Looking to the future. appeared first on.

Marketing 98

Marketing Antibody Drugs Clinical Trials 98

World of DTC Marketing

APRIL 12, 2021

QUICK READ: Pharma supply chain issues are a concern for us all but especially patients. The goal of getting a drug to market as fast as possible so they can recoup drug development costs has the potential for mistakes that could cost lives. Why would a pharma company take risks like these? Patients should be scared.

Generic Drugs 187

Generic Drugs Manufacturing Drugs Production 187

World of DTC Marketing

AUGUST 5, 2020

First, the pharma ecosystem of constant meetings and matrix organizations lead to watered-down cutting edge marketing. When the publics level of trust in pharma goes up and stays there that is the best award any company can receive. The frustration is largely due to two reasons. Then there is the agency side.

Vaccination 180

Vaccination Vaccine Pharma Companies Clinical Trials 180

Delveinsight

SEPTEMBER 3, 2021

Further, there exist no curative therapies in the Charcot-Marie-Tooth disease market. The present CMT disease therapeutics market is purely based on supportive and symptomatic management that includes occupational therapies, physiotherapy, ankle-foot orthoses (AFO), and shoe inserts. The condition has no cure at hand.

Pharma Companies 52

Pharma Companies Marketing Clinical Trials Clinical Trials 52

World of DTC Marketing

JANUARY 31, 2021

Smaller biotechs that are developing new drugs usually don’t have the resources to take new drugs to market. The venture capitalists funding them are looking for a big payday when a pharma company acquires them. In pharma R&D returns have declined to 1.8 In pharma R&D returns have declined to 1.8

In-Vivo 187

In-Vivo Generic Drugs Drugs Gene Therapy 187

pharmaphorum

NOVEMBER 1, 2021

Daiichi Sankyo has launched its oncolytic virus therapy Delytact in Japan – its first world market – as a treatment for malignant glioma, an aggressive form of brain cancer. million yen (around $12,500) per dose, according to a Pharma Japan report.

Genetic Engineering 122

Genetic Engineering Clinical Trials Clinical Trials Trials 122

pharmaphorum

AUGUST 26, 2021

The pandemic has transformed many aspects of our industry and one area that change has come to is patient engagement within clinical trials, where it would now seem unusual were we to not consider the patient voice when it comes to recruiting trial participants. Boosting clinical trial recruitment with digital marketing.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Marketing 105

pharmaphorum

JULY 14, 2022

A pilot study has been launched by the EMA to see whether it is helpful for regulators to look at the ‘raw data’ from clinical trials submitted in support of new marketing application along with the usual structured analyses from sponsors.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Regulation 52

Pharma Marketing Network

FEBRUARY 5, 2025

Table of Contents Sr# Headings 1 Understanding Pharmaceutical Market Access 2 Challenges in Pharmaceutical Market Access 3 Key Strategies for Market Access Success 4 Emerging Trends Shaping Market Access Understanding Pharmaceutical Market Access Bringing a new drug to market is only part of the battle.

Marketing 52

Marketing Pharma Companies Drugs Regulation 52

pharmaphorum

MARCH 23, 2022

Whether you’re a large pharma company or a small, emerging one, communication is key. Florent has served in various roles within the healthcare industry for almost 20 years and is MIT-certified in digital marketing analytics and digital business strategy. Mark Mulder is vice president, commercial, Europe, at EVERSANA.

Clinical Trials 105

Clinical Trials Clinical Trials Sales Marketing 105